SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 70 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | -50.0% | 4,732 | +27.7% | 0.00% | – |
| Q4 2021 | $12,000 | -62.5% | 3,706 | -47.5% | 0.00% | -100.0% |
| Q3 2021 | $32,000 | +128.6% | 7,062 | +168.8% | 0.00% | – |
| Q2 2021 | $14,000 | -22.2% | 2,627 | +9.4% | 0.00% | -100.0% |
| Q1 2021 | $18,000 | +5.9% | 2,402 | +52.1% | 0.00% | 0.0% |
| Q4 2020 | $17,000 | -29.2% | 1,579 | -41.9% | 0.00% | -66.7% |
| Q3 2020 | $24,000 | +700.0% | 2,720 | +1302.1% | 0.00% | +50.0% |
| Q3 2017 | $3,000 | – | 194 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|